Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Prolifix identifies hydroxamate-based inhibitors of HDAC with antitumor activity

April 18, 2002

Clinical trials with botulinum toxins reported at the AAN meeting

April 18, 2002

New clinical trial results with mitoxantrone reported at this week's AAN meeting

April 18, 2002

Histamine H3 receptor agonist discovered by European team

April 18, 2002

Clinical trials of drugs in development for neurological disorders presented in Denver

April 18, 2002

Improved HIV protease inhibitors discovered at Merck & Co.

April 18, 2002

Orally active VEGFR tyrosine kinase inhibitor RWJ-417975 exerts antitumor activity in mouse models

April 18, 2002

AVI-4126 may be useful alone or in combination in the treatment of prostate cancer

April 17, 2002

Semisynthetic andrographolide analogue with immunomodulating and antitumor activity

April 17, 2002

AACR presentations provide further preclinical characterization of epothilone D

April 17, 2002

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...